Roy Mano
Impact in
-
- Renal cell carcinoma treatment
- Kidney Stones and Urolithiasis Treatments
- Urology top 5%
Papers in
-
- Renal cell carcinoma treatment 28
- Prostate Cancer Diagnosis and Treatment 10
- Kidney Stones and Urolithiasis Treatments 7
- Renal and Vascular Pathologies 5
- Surgery 32
- Bladder and Urothelial Cancer Treatments 24
- Testicular diseases and treatments 5
- Co-authors
- Jack Baniel (22 shared papers)Ofer Yossepowitch (41 shared papers)Paul Russo (36 shared papers)A. Ari Hakimi (37 shared papers)Amihay Nevo (8 shared papers)Jonathan Coleman (26 shared papers)David Lifshitz (7 shared papers)David Margel (16 shared papers)
- Journals
- The Journal of Urology (16 papers)Urologic Oncology Seminars and Original Investigations (15 papers)Urology (14 papers)British Journal of Urology (6 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- IsraelUnited StatesAustralia
In The Last Decade
Roy Mano
105 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 81
- Pulmonary and Respiratory Medicine 707
- Urology 76
- Cancer Research 174
- Surgery 406
- Oncology 220
Countries citing papers authored by Roy Mano
This map shows the geographic impact of Roy Mano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Mano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Mano more than expected).
Fields of papers citing papers by Roy Mano
This network shows the impact of papers produced by Roy Mano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Mano. The network helps show where Roy Mano may publish in the future.
Co-authors
The 25 scholars most cited alongside Roy Mano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 129 | |
| 2 | 2015 | 125 | |
| 3 | 2014 | 96 | |
| 4 | 2014 | 93 | |
| 5 | 2017 | 85 | |
| 6 | 2016 | 36 | |
| 7 | 2015 | 36 | |
| 8 | 2020 | 34 | |
| 9 | 2016 | 32 | |
| 10 | 2015 | 31 | |
| 11 | 2018 | 31 | |
| 12 | 2013 | 27 | |
| 13 | 2013 | 25 | |
| 14 | 2013 | 25 | |
| 15 | 2014 | 23 | |
| 16 | 2016 | 23 | |
| 17 | 2012 | 22 | |
| 18 | 2018 | 22 | |
| 19 | 2017 | 21 | |
| 20 | 2019 | 20 |
About Roy Mano
Roy Mano is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Molecular Biology, Oncology and Cancer Research, having authored 110 papers that have together received 1.5k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (28 papers), Bladder and Urothelial Cancer Treatments (24 papers), Prostate Cancer Diagnosis and Treatment (10 papers), Renal and related cancers (8 papers), Kidney Stones and Urolithiasis Treatments (7 papers), Renal and Vascular Pathologies (5 papers), Cancer Genomics and Diagnostics (5 papers) and Testicular diseases and treatments (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (707 citations), Urology (76 citations), Cancer Research (174 citations), Surgery (406 citations) and Oncology (220 citations). Roy Mano has collaborated with scholars based in Israel, United States and Australia. Frequent co-authors include Jack Baniel, Ofer Yossepowitch, Paul Russo, A. Ari Hakimi, Amihay Nevo, Jonathan Coleman, David Lifshitz, David Margel, Alexander Sankin and Renzo G. DiNatale. Their work appears in journals such as The Journal of Urology, Urologic Oncology Seminars and Original Investigations, Urology, British Journal of Urology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.